Aspirin Minimized the Pro-Metastasis Effect of Sorafenib and Improved Survival by Up-Regulating HTATIP2 in Hepatocellular Carcinoma

• Lu Lu ,

  Contributed equally to this work with: Lu Lu, Hui-Chuan Sun, Wei Zhang

  Affiliation Liver Cancer Institute and Zhongshan Hospital, Fudan University; Key Laboratory for Carcinogenesis and Cancer Invasion, The Chinese Ministry of Education, Shanghai, P.R. China

  ⨯
• Hui-Chuan Sun ,

  Contributed equally to this work with: Lu Lu, Hui-Chuan Sun, Wei Zhang

  Affiliation Liver Cancer Institute and Zhongshan Hospital, Fudan University; Key Laboratory for Carcinogenesis and Cancer Invasion, The Chinese Ministry of Education, Shanghai, P.R. China

  ⨯
• Wei Zhang ,

  Contributed equally to this work with: Lu Lu, Hui-Chuan Sun, Wei Zhang

  Affiliation Department of Hepatobiliary Surgery, Tianjin Medical University Cancer Institute and Hospital (TJCIH); Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin, P.R. China

  ⨯
• Zong-Tao Chai,

  Affiliation Liver Cancer Institute and Zhongshan Hospital, Fudan University; Key Laboratory for Carcinogenesis and Cancer Invasion, The Chinese Ministry of Education, Shanghai, P.R. China

  ⨯
• Xiao-Dong Zhu,

  Affiliation Liver Cancer Institute and Zhongshan Hospital, Fudan University; Key Laboratory for Carcinogenesis and Cancer Invasion, The Chinese Ministry of Education, Shanghai, P.R. China

  ⨯
• Ling-Qun Kong,

  Affiliation Liver Cancer Institute and Zhongshan Hospital, Fudan University; Key Laboratory for Carcinogenesis and Cancer Invasion, The Chinese Ministry of Education, Shanghai, P.R. China

  ⨯
• Wen-Quan Wang,

  Affiliation Department of Hepatobiliary and Pancreatic Surgery, Cancer Hospital/Cancer Institute, Fudan University, Shanghai, P.R. China

  ⨯
• Ke-Zhi Zhang,

  Affiliation Liver Cancer Institute and Zhongshan Hospital, Fudan University; Key Laboratory for Carcinogenesis and Cancer Invasion, The Chinese Ministry of Education, Shanghai, P.R. China

  ⨯
• Yuan-Yuan Zhang,

  Affiliation Liver Cancer Institute and Zhongshan Hospital, Fudan University; Key Laboratory for Carcinogenesis and Cancer Invasion, The Chinese Ministry of Education, Shanghai, P.R. China

  ⨯
• Qiang-Bo Zhang,

  Affiliation Liver Cancer Institute and Zhongshan Hospital, Fudan University; Key Laboratory for Carcinogenesis and Cancer Invasion, The Chinese Ministry of Education, Shanghai, P.R. China

  ⨯
• Jian-Yang Ao,

  Affiliation Liver Cancer Institute and Zhongshan Hospital, Fudan University; Key Laboratory for Carcinogenesis and Cancer Invasion, The Chinese Ministry of Education, Shanghai, P.R. China

  ⨯
• Jia-Qi Li,

  Affiliation Liver Cancer Institute and Zhongshan Hospital, Fudan University; Key Laboratory for Carcinogenesis and Cancer Invasion, The Chinese Ministry of Education, Shanghai, P.R. China

  ⨯
• Lu Wang,

  Affiliation Liver Cancer Institute and Zhongshan Hospital, Fudan University; Key Laboratory for Carcinogenesis and Cancer Invasion, The Chinese Ministry of Education, Shanghai, P.R. China

  ⨯
• Wei-Zhong Wu,

  Affiliation Liver Cancer Institute and Zhongshan Hospital, Fudan University; Key Laboratory for Carcinogenesis and Cancer Invasion, The Chinese Ministry of Education, Shanghai, P.R. China

  ⨯
• Zhao-You Tang

  * E-mail: zytang88@163.com

  Affiliation Liver Cancer Institute and Zhongshan Hospital, Fudan University; Key Laboratory for Carcinogenesis and Cancer Invasion, The Chinese Ministry of Education, Shanghai, P.R. China

  ⨯